CVS
27
2
IRM
33
5
F
38
4
PM
49
8
IR
46
3
WBA
41
3
BIIB
36
8
GILD
55
5
HD
43
8
LMT
29
-5
ICE
53
5
SBUX
29
-2
FAST
41
7
MO
47
6
A
43
2
LEN
21
3
SNA
56
3
EQT
47
13
GM
55
6
INTU
54
2
CVS
27
2
IRM
33
5
F
38
4
PM
49
8
IR
46
3
WBA
41
3
BIIB
36
8
GILD
55
5
HD
43
8
LMT
29
-5
ICE
53
5
SBUX
29
-2
FAST
41
7
MO
47
6
A
43
2
LEN
21
3
SNA
56
3
EQT
47
13
GM
55
6
INTU
54
2
Financhill
Back

Gilead Sciences 10K Form

Buy
55

GILD
Gilead Sciences

Last Price:
$92.57
Seasonality Move:
8.55%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

2024-05-08 10Q GILD/Gilead Sciences Quarterly
2024-02-23 10K GILD/Gilead Sciences Annual
2023-11-07 10Q GILD/Gilead Sciences Quarterly
2023-08-04 10Q GILD/Gilead Sciences Quarterly
2023-05-03 10Q GILD/Gilead Sciences Quarterly
2023-02-22 10K GILD/Gilead Sciences Annual

Receive GILD News And Ratings

See the #1 stock for the next 7 days that we like better than GILD

GILD Financial Statistics

Sales & Book Value

Annual Sales: $27.1B
Cash Flow: $4.2B
Price / Cash Flow: 12.29
Annual Sales: $14.83
Price / Book: 6.24

Profitability

EPS (TTM): 0.09000
Net Income (TTM): $126M
Gross Margin: $20.6B
Return on Equity: 0.64%
Return on Assets: 0.22%

Gilead Sciences Earnings Forecast

Key Gilead Sciences Financial Ratios

  • The Gross Profit Margin over the past 33 years for GILD is 76.04%.
  • The Selling, General & Administrative Expenses for GILD have been equal to 22.46% of Gross Profit Margin.
  • The Research & Development expenses have been 21.09% of Revenue.
  • The Interest Expense is 16.66% of Operating Income.
  • The Net Earning history of GILD is 20.89% of Total Revenues.
  • Per Share Earnings over the last 33 years have been positive in 20 years.

Gilead Sciences Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: S&P500
Industry: Biotechnology
Sector: Health Care
Current Symbol: GILD
CUSIP: 375558
Website: gilead.com

Debt

Debt-to-Equity Ratio: 1.26
Current Ratio: 1.26
Quick Ratio: 0.82

Price-to-Earnings

Trailing P/E Ratio: 20.57
Forward P/E Ratio: 12.23

GILD Technical Analysis vs Fundamental Analysis

Buy
55
Gilead Sciences (GILD) is a Buy

Is Gilead Sciences a Buy or a Sell?

  • Gilead Sciences stock is rated a Buy
    The current Gilead Sciences [GILD] share price is $92.57. The Score for GILD is 55, which is 10% above its historic median score of 50, and infers lower risk than normal.